07 Feb 2025
// PRESS RELEASE
24 Jan 2025
// PRESS RELEASE
16 Jan 2025
// FDA
Latest Content by PharmaCompass
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
About
Product(s) under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale
Industry Trade Show
Attending
17-20 March, 2025
Industry Trade Show
Attending
24-26 February, 2025
Industry Trade Show
Booth #5N-12
09-11 April, 2025
CONTACT DETAILS
Events
Webinars & Exhibitions
Industry Trade Show
Attending
17-20 March, 2025
Industry Trade Show
Attending
24-26 February, 2025
Industry Trade Show
Booth #5N-12
09-11 April, 2025
VLOG #PharmaReel
CORPORATE CONTENT #SupplierSpotlight
https://www.pharmacompass.com/radio-compass-blog/fda-okays-50-new-drugs-in-2024-bms-cobenfy-lilly-s-kisunla-lead-pack-of-breakthrough-therapies
https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-bora-polpharma-make-acquisitions-evonik-euroapi-porton-announce-technological-expansions
https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions